Dianthus Therapeutics, Inc. (DNTH)
82.37
-0.06
(-0.07%)
USD |
NASDAQ |
Oct 09, 16:00
83.00
+0.63
(+0.76%)
After-Hours: 20:00
Dianthus Therapeutics Market Cap : 4.514B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 4.514B |
| October 08, 2026 | 4.517B |
| October 07, 2026 | 4.651B |
| October 06, 2026 | 4.680B |
| October 05, 2026 | 4.824B |
| October 02, 2026 | 4.834B |
| October 01, 2026 | 4.840B |
| September 30, 2026 | 4.825B |
| September 29, 2026 | 4.776B |
| September 28, 2026 | 4.813B |
| September 25, 2026 | 4.852B |
| September 24, 2026 | 4.971B |
| September 23, 2026 | 5.120B |
| September 22, 2026 | 5.389B |
| September 21, 2026 | 5.286B |
| September 18, 2026 | 5.305B |
| September 17, 2026 | 5.541B |
| September 16, 2026 | 5.616B |
| September 15, 2026 | 5.741B |
| September 14, 2026 | 5.901B |
| September 11, 2026 | 5.820B |
| September 10, 2026 | 5.660B |
| September 09, 2026 | 5.866B |
| September 08, 2026 | 5.980B |
| September 04, 2026 | 5.924B |
| Date | Value |
|---|---|
| September 03, 2026 | 5.910B |
| September 02, 2026 | 5.822B |
| September 01, 2026 | 5.843B |
| August 31, 2026 | 5.787B |
| August 28, 2026 | 5.800B |
| August 27, 2026 | 6.112B |
| August 26, 2026 | 6.069B |
| August 25, 2026 | 6.143B |
| August 24, 2026 | 6.032B |
| August 21, 2026 | 6.088B |
| August 20, 2026 | 6.001B |
| August 19, 2026 | 6.231B |
| August 18, 2026 | 6.331B |
| August 17, 2026 | 6.294B |
| August 14, 2026 | 6.354B |
| August 13, 2026 | 6.006B |
| August 12, 2026 | 6.160B |
| August 11, 2026 | 5.945B |
| August 10, 2026 | 6.126B |
| August 07, 2026 | 5.969B |
| August 06, 2026 | 6.023B |
| August 05, 2026 | 6.165B |
| August 04, 2026 | 6.050B |
| August 03, 2026 | 5.810B |
| July 31, 2026 | 5.836B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Verastem, Inc. | 758.24M |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.011B |
Market Cap Related Metrics
| PS Ratio | 2020.61 |
| PEG Ratio | -0.7196 |
| Price to Book Value | 3.851 |
| Price | 82.37 |
| Earnings Yield | -5.04% |
| PEGY Ratio | -0.7196 |